LONDON–(BUSINESS WIRE)–Calla Lily Clinical Care, a clinical-stage women’s health company, today announced it has been awarded a £700k Innovate UK grant through its Growth Catalyst: Investor Partnerships programme, which pairs grant funding with matched private investment. The grant supports a £1M project, co-funded by Innovate UK, to adapt its patented Callavid® platform for the delivery of live biotherapeutic products (LBPs) and probiotics aimed at restoring vaginal microbiome health. The ne

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.